Condition
Precocious Puberty, Central
Total Trials
3
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Completed1
Unknown1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07411001Not ApplicableActive Not RecruitingPrimary
Hypiend - Multicomponent Behavioral Intervention in Pre-puberal Children (Hypiend-PPC)
NCT02452931Phase 3CompletedPrimary
Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty
NCT02974270Phase 4UnknownPrimary
Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate
Showing all 3 trials